Qrativ

Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical
Founded in 2017-01-01
Cambridge, Massachusetts, United States
http://qrativ.bio
For Profit

About Qrativ

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical need are discovered and developed. The company's platform ,Darwin.ai, identifies new uses for existing molecules for diseases with unmet medical need and uses machine learning and artificial intelligence for research and development, enabling patient to get treatments for diseases for which drugs are not available in the market.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 8300000 USD
  • Last Funding: 8300000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Qrativ actively uses None products in their tech stack.

Market Presence

Industries: Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical

Headquarters: Cambridge, Massachusetts, United States